<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36446586</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Radiogenomics of <i>C9orf72</i> Expansion Carriers Reveals Global Transposable Element Derepression and Enables Prediction of Thalamic Atrophy and Clinical Impairment.</ArticleTitle><Pagination><StartPage>333</StartPage><EndPage>345</EndPage><MedlinePgn>333-345</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.1448-22.2022</ELocationID><Abstract><AbstractText>Hexanucleotide repeat expansion (HRE) within <i>C9orf72</i> is the most common genetic cause of frontotemporal dementia (FTD). Thalamic atrophy occurs in both sporadic and familial FTD but is thought to distinctly affect HRE carriers. Separately, emerging evidence suggests widespread derepression of transposable elements (TEs) in the brain in several neurodegenerative diseases, including <i>C9orf72</i> HRE-mediated FTD (C9-FTD). Whether TE activation can be measured in peripheral blood and how the reduction in peripheral <i>C9orf72</i> expression observed in HRE carriers relates to atrophy and clinical impairment remain unknown. We used FreeSurfer software to assess the effects of <i>C9orf72</i> HRE and clinical diagnosis (<i>n</i> = 78 individuals, male and female) on atrophy of thalamic nuclei. We also generated a novel, human, whole-blood RNA-sequencing dataset to determine the relationships among peripheral <i>C9orf72</i> expression, TE activation, thalamic atrophy, and clinical severity (<i>n</i> = 114 individuals, male and female). We confirmed global thalamic atrophy and reduced <i>C9orf72</i> expression in HRE carriers. Moreover, we identified disproportionate atrophy of the right mediodorsal lateral nucleus in HRE carriers and showed that <i>C9orf72</i> expression associated with clinical severity, independent of thalamic atrophy. Strikingly, we found global peripheral activation of TEs, including the human endogenous LINE-1 element <i>L1HS</i> <i>L1HS</i> levels were associated with atrophy of multiple pulvinar nuclei, a thalamic region implicated in C9-FTD. Integration of peripheral transcriptomic and neuroimaging data from human HRE carriers revealed atrophy of specific thalamic nuclei, demonstrated that <i>C9orf72</i> levels relate to clinical severity, and identified marked derepression of TEs, including <i>L1HS</i>, which predicted atrophy of FTD-relevant thalamic nuclei.<b>SIGNIFICANCE STATEMENT</b> Pathogenic repeat expansion in <i>C9orf72</i> is the most frequent genetic cause of FTD and amyotrophic lateral sclerosis (ALS; C9-FTD/ALS). The clinical, neuroimaging, and pathologic features of C9-FTD/ALS are well characterized, whereas the intersections of transcriptomic dysregulation and brain structure remain largely unexplored. Herein, we used a novel radiogenomic approach to examine the relationship between peripheral blood transcriptomics and thalamic atrophy, a neuroimaging feature disproportionately impacted in C9-FTD/ALS. We confirmed reduction of <i>C9orf72</i> in blood and found broad dysregulation of transposable elements-genetic elements typically repressed in the human genome-in symptomatic <i>C9orf72</i> expansion carriers, which associated with atrophy of thalamic nuclei relevant to FTD. <i>C9orf72</i> expression was also associated with clinical severity, suggesting that peripheral <i>C9orf72</i> levels capture disease-relevant information.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Bonham et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonham</LastName><ForeName>Luke W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geier</LastName><ForeName>Ethan G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Transposon Therapeutics, San Diego, California 92122.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirkis</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><Identifier Source="ORCID">0000-0003-3440-8859</Identifier><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong</LastName><ForeName>Josiah K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychological Science, University of Arkansas, Fayetteville, Arkansas 72701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Eliana Marisa</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karydas</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Suzee E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturm</LastName><ForeName>Virginia E</ForeName><Initials>VE</Initials><Identifier Source="ORCID">0000-0002-1717-298X</Identifier><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawyer</LastName><ForeName>Russell P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedberg</LastName><ForeName>Adit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichida</LastName><ForeName>Justin K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California 90033.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gitler</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, California 94305.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordingley</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Transposon Therapeutics, San Diego, California 92122.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bee</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Transposon Therapeutics, San Diego, California 92122.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Eckard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Transposon Therapeutics, San Diego, California 92122.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Joel H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rankin</LastName><ForeName>Katherine P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Howard J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boxer</LastName><ForeName>Adam L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeley</LastName><ForeName>William W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, ALS Translational Research, University of California, San Diego, La Jolla, California 92093.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-2152-4220</Identifier><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158 jennifer.yokoyama@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, San Francisco, California 94158, and Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG071756</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AG045333</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG057234</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG063911</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052496</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG019724</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038791</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG049152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG045390</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062588</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058233</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG073482</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS123985</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004251">DNA Transposable Elements</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004251" MajorTopicYN="N">DNA Transposable Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">radiogenomics</Keyword><Keyword MajorTopicYN="N">thalamus</Keyword><Keyword MajorTopicYN="N">transposable elements</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36446586</ArticleId><ArticleId IdType="pmc">PMC9838702</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1448-22.2022</ArticleId><ArticleId IdType="pii">JNEUROSCI.1448-22.2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chaer ED, Lawand NB, Westlund KN, Willis WD (1996) Visceral nociceptive input into the ventral posterolateral nucleus of the thalamus: a new function for the dorsal column pathway. J Neurophysiol 76:2661&#x2013;2674. 10.1152/jn.1996.76.4.2661</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1996.76.4.2661</ArticleId><ArticleId IdType="pubmed">8899636</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544&#x2013;558. 10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A, Knehr A, Finsel J, Kunz MS, Lang C, M&#xfc;ller K, M&#xfc;ller H-P, Pinkhardt EH, Ludolph AC, Lul&#xe9; D, Kassubek J (2021) Eye movement alterations in presymptomatic C9orf72 expansion gene carriers. J Neurol 268:3390&#x2013;3399. 10.1007/s00415-021-10510-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10510-z</ArticleId><ArticleId IdType="pmc">PMC8357645</ArticleId><ArticleId IdType="pubmed">33709219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettcher BM, Tansey MG, Doroth&#xe9;e G, Heneka MT (2021) Peripheral and central immune system crosstalk in Alzheimer disease&#x2014;a research prospectus. Nat Rev Neurol 17:689&#x2013;701. 10.1038/s41582-021-00549-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00549-x</ArticleId><ArticleId IdType="pmc">PMC8439173</ArticleId><ArticleId IdType="pubmed">34522039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Gordon E, Cardoso MJ, Modat M, Ourselin S, Warren JD, Rohrer JD (2018) Thalamic atrophy in frontotemporal dementia&#x2014;not just a C9orf72 problem. Neuroimage Clin 18:675&#x2013;681. 10.1016/j.nicl.2018.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.02.019</ArticleId><ArticleId IdType="pmc">PMC5988457</ArticleId><ArticleId IdType="pubmed">29876259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Iglesias JE, Neason M, Cash DM, Warren JD, Rohrer JD (2020) Thalamic nuclei in frontotemporal dementia: mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72. Hum Brain Mapp 41:1006&#x2013;1016. 10.1002/hbm.24856</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24856</ArticleId><ArticleId IdType="pmc">PMC7267940</ArticleId><ArticleId IdType="pubmed">31696638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourque G, Burns KH, Gehring M, Gorbunova V, Seluanov A, Hammell M, Imbeault M, Izsv&#xe1;k Z, Levin HL, Macfarlan TS, Mager DL, Feschotte C (2018) Ten things you should know about transposable elements. Genome Biol 19:199. 10.1186/s13059-018-1577-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1577-z</ArticleId><ArticleId IdType="pmc">PMC6240941</ArticleId><ArticleId IdType="pubmed">30454069</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E, Swinnen B, Van Den Bosch L (2020) C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol 140:625&#x2013;643. 10.1007/s00401-020-02214-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="pubmed">32876811</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, Gillet G, van Gastel N, Wang J-Y, Pietilainen O, Qian M, Eggan P, Cantrell C, Mok J, Kadiu I, Scadden DT, Eggan K (2020) C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582:89&#x2013;94. 10.1038/s41586-020-2288-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y-H, Dubnau J (2019) The gypsy endogenous retrovirus drives non-cell-autonomous propagation in a Drosophila TDP-43 model of neurodegeneration. Curr Biol 29:3135&#x2013;3152.e4. 10.1016/j.cub.2019.07.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2019.07.071</ArticleId><ArticleId IdType="pmc">PMC6783360</ArticleId><ArticleId IdType="pubmed">31495585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, Kabashi E (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 74:180&#x2013;187. 10.1002/ana.23946</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Darian-Smith C, Tan A, Edwards S (1999) Comparing thalamocortical and corticothalamic microstructure and spatial reciprocity in the macaque ventral posterolateral nucleus (VPLc) and medial pulvinar. J Comp Neurol 410:211&#x2013;234. 10.1002/(SICI)1096-9861(19990726)410:2&lt;211::AID-CNE4&gt;3.0.CO;2-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19990726)410:2&lt;211::AID-CNE4&gt;3.0.CO;2-X</ArticleId><ArticleId IdType="pubmed">10414528</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cecco M, et al. . (2019) L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566:73&#x2013;78. 10.1038/s41586-018-0784-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0784-9</ArticleId><ArticleId IdType="pmc">PMC6519963</ArticleId><ArticleId IdType="pubmed">30728521</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejesus-Hernandez M, et al. . (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, S&#xe9;gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968&#x2013;980. 10.1016/j.neuroimage.2006.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.01.021</ArticleId><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15&#x2013;21. 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341&#x2013;355. 10.1016/s0896-6273(02)00569-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(02)00569-x</ArticleId><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR (1975) &#x201c;Mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189&#x2013;198. 10.1016/0022-3956(75)90026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fort-Aznar L, Ugbode C, Sweeney ST (2020) Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia. Hum Mol Genet 29:2637&#x2013;2646. 10.1093/hmg/ddaa142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa142</ArticleId><ArticleId IdType="pmc">PMC7530534</ArticleId><ArticleId IdType="pubmed">32628265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, et al. . (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54&#x2013;65. 10.1016/S1474-4422(11)70261-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, et al. . (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006&#x2013;1014. 10.1212/WNL.0b013e31821103e6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32:2847&#x2013;2849. 10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Jeong H-H, Hsieh Y-C, Klein H-U, Bennett DA, De Jager PL, Liu Z, Shulman JM (2018) Tau activates transposable elements in Alzheimer's disease. Cell Rep 23:2874&#x2013;2880. 10.1016/j.celrep.2018.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.004</ArticleId><ArticleId IdType="pmc">PMC6181645</ArticleId><ArticleId IdType="pubmed">29874575</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias JE, Insausti R, Lerma-Usabiaga G, Bocchetta M, Van Leemput K, Greve DN, van der Kouwe A, Fischl B, Caballero-Gaudes C, Paz-Alonso PM (2018) A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology. Neuroimage 183:314&#x2013;326. 10.1016/j.neuroimage.2018.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.08.012</ArticleId><ArticleId IdType="pmc">PMC6215335</ArticleId><ArticleId IdType="pubmed">30121337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas A, Pizarro D, Romeo AK, Riley KO, Pati S (2019) The centromedian nucleus: anatomy, physiology, and clinical implications. J Clin Neurosci 63:1&#x2013;7. 10.1016/j.jocn.2019.01.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.01.050</ArticleId><ArticleId IdType="pubmed">30827880</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Hammell M (2018) Analysis of RNA-seq data using TEtranscripts. Methods Mol Biol 1751:153&#x2013;167. 10.1007/978-1-4939-7710-9_11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7710-9_11</ArticleId><ArticleId IdType="pubmed">29508296</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Tam OH, Paniagua E, Hammell M (2015) TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics 31:3593&#x2013;3599. 10.1093/bioinformatics/btv422</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv422</ArticleId><ArticleId IdType="pmc">PMC4757950</ArticleId><ArticleId IdType="pubmed">26206304</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause T, Brunecker P, Pittl S, Taskin B, Laubisch D, Winter B, Lentza ME, Malzahn U, Villringer K, Villringer A, Jungehulsing GJ (2012) Thalamic sensory strokes with and without pain: differences in lesion patterns in the ventral posterior thalamus. J Neurol Neurosurg Psychiatry 83:776&#x2013;784. 10.1136/jnnp-2011-301936</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301936</ArticleId><ArticleId IdType="pubmed">22696587</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L, Chatterjee N, Borges-Monroy R, Hearn S, Liao W-W, Morrill K, Prazak L, Rozhkov N, Theodorou D, Hammell M, Dubnau J (2017) Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLOS Genet 13:e1006635. 10.1371/journal.pgen.1006635</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, et al. . (2014) Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain 137:3047&#x2013;3060. 10.1093/brain/awu248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu248</ArticleId><ArticleId IdType="pmc">PMC4208465</ArticleId><ArticleId IdType="pubmed">25273996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, Vidovszky AA, Zanto TP, Karydas AM, Pribadi M, Dokuru D, Coppola G, Geschwind DH, Rademakers R, Gorno-Tempini ML, Rosen HJ, Miller BL, Seeley WW (2017) Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin 14:286&#x2013;297. 10.1016/j.nicl.2016.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5349617</ArticleId><ArticleId IdType="pubmed">28337409</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Jin Y, Prazak L, Hammell M, Dubnau J (2012) Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One 7:e44099. 10.1371/journal.pone.0044099</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044099</ArticleId><ArticleId IdType="pmc">PMC3434193</ArticleId><ArticleId IdType="pubmed">22957047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB (2019) Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep 27:1409&#x2013;1421.e6. 10.1016/j.celrep.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. 10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Neumann M (2016) Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem 138:54&#x2013;70. 10.1111/jnc.13588</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13588</ArticleId><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai JK, Forutan F (2012) Thalamus. In: The human nervous system (Mai JK, Paxinos G, eds), pp 618&#x2013;677. Amsterdam: Elsevier Academic Press.</Citation></Reference><Reference><Citation>McCauley ME, O'Rourke JG, Y&#xe1;&#xf1;ez A, Markman JL, Ho R, Wang X, Chen S, Lall D, Jin M, Muhammad AKMG, Bell S, Landeros J, Valencia V, Harms M, Arditi M, Jefferies C, Baloh RH (2020) C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585:96&#x2013;101. 10.1038/s41586-020-2625-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna MC, Shing SLH, Murad A, Lope J, Hardiman O, Hutchinson S, Bede P (2022) Focal thalamus pathology in frontotemporal dementia: phenotype-associated thalamic profiles. J Neurol Sci 436:120221. 10.1016/j.jns.2022.120221</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120221</ArticleId><ArticleId IdType="pubmed">35279595</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA, Mandelli ML, Rankin KP, Henry ML, Babiak MC, Frazier DT, Lobach IV, Bettcher BM, Wu TQ, Rabinovici GD, Graff-Radford NR, Miller BL, Gorno-Tempini ML (2013) Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 136:3461&#x2013;3473. 10.1093/brain/awt242</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt242</ArticleId><ArticleId IdType="pmc">PMC3808687</ArticleId><ArticleId IdType="pubmed">24056533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AS, Chakraborty S (2013) What does the mediodorsal thalamus do? Front Syst Neurosci 7:37. 10.3389/fnsys.2013.00037</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2013.00037</ArticleId><ArticleId IdType="pmc">PMC3738868</ArticleId><ArticleId IdType="pubmed">23950738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK, et al. . (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267&#x2013;273. 10.1038/ng1180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1180</ArticleId><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412&#x2013;2414. 10.1212/wnl.43.11.2412-a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.43.11.2412-a</ArticleId><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Y&#xe1;&#xf1;ez A, Lall D, Wolf AJ, Muhammad AKMG, Ho R, Carmona S, Vit JP, Zarrow J, Kim KJ, Bell S, Harms MB, Miller TM, Dangler CA, Underhill DM, Goodridge HS, Lutz CM, Baloh RH (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science 351:1324&#x2013;1329. 10.1126/science.aaf1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouhaz Z, Fleming H, Mitchell AS (2018) Cognitive functions and neurodevelopmental disorders involving the prefrontal cortex and mediodorsal thalamus. Front Neurosci 12:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5808198</ArticleId><ArticleId IdType="pubmed">29467603</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikshak NN, Swarup V, Belgard TG, Irimia M, Ramaswami G, Gandal MJ, Hartl C, Leppa V, Ubieta L, de la T, Huang J, Lowe JK, Blencowe BJ, Horvath S, Geschwind DH (2016) Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature 540:423&#x2013;427. 10.1038/nature20612</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20612</ArticleId><ArticleId IdType="pmc">PMC7102905</ArticleId><ArticleId IdType="pubmed">27919067</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GC, Sanchez L, Schaughency PM, Rubio-Rold&#xe1;n A, Choi JA, Planet E, Batra R, Turelli P, Trono D, Ostrow LW, Ravits J, Kazazian HH, Wheelan SJ, Heras SR, Mayer J, Garc&#xed;a-P&#xe9;rez JL, Goodier JL (2018) Properties of LINE-1 proteins and repeat element expression in the context of amyotrophic lateral sclerosis. Mob DNA 9:35. 10.1186/s13100-018-0138-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-018-0138-z</ArticleId><ArticleId IdType="pmc">PMC6295051</ArticleId><ArticleId IdType="pubmed">30564290</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303&#x2013;308. 10.1001/archneur.56.3.303</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.3.303</ArticleId><ArticleId IdType="pubmed">10190820</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L (2014) Mild cognitive impairment: a concept in evolution. J Intern Med 275:214&#x2013;228. 10.1111/joim.12190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12190</ArticleId><ArticleId IdType="pmc">PMC3967548</ArticleId><ArticleId IdType="pubmed">24605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinilla G, Kumar A, Floaters MK, Pardo CA, Rothstein J, Ilieva H (2021) Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients. Amyotroph Lateral Scler Frontotemporal Degener 22:517&#x2013;527. 10.1080/21678421.2021.1912100</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1912100</ArticleId><ArticleId IdType="pubmed">33929933</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Gonzales PK, Cook CN, Gendron TF, Daughrity LM, Song Y, Ebbert MTW, van Blitterswijk M, Zhang Y-J, Jansen-West K, Baker MC, DeTure M, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Link CD (2017) Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum Mol Genet 26:3421&#x2013;3431. 10.1093/hmg/ddx233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx233</ArticleId><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Purves D, Williams SM (2001) Neuroscience. Sunderland, MA: Sinauer Associates.</Citation></Reference><Reference><Citation>Rankin KP, Kramer JH, Miller BL (2005) Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol 18:28&#x2013;36. 10.1097/01.wnn.0000152225.05377.ab</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wnn.0000152225.05377.ab</ArticleId><ArticleId IdType="pubmed">15761274</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, et al. . (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;2477. 10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. . (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, Pyz E, Hobert M, Synofzik M, Sim&#xf3;n-S&#xe1;nchez J, Francescatto M, Heutink P (2016) C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol Commun 4:37. 10.1186/s40478-016-0306-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0306-7</ArticleId><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez S, Sahin A, Schrank BR, Al-Lawati H, Costantino I, Benz E, Fard D, Albers AD, Cao L, Gomez AC, Evans K, Ratti E, Cudkowicz M, Frosch MP, Talkowski M, Sorger PK, Hyman BT, Albers MW (2021) Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss. Sci Transl Med 13:eaaz4699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8779652</ArticleId><ArticleId IdType="pubmed">34233951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;necker S, et al. . (2018) Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients&#x2014;an atlas-based volumetric MRI study. Front Aging Neurosci 10:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863593</ArticleId><ArticleId IdType="pubmed">29599716</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW, Crawford R, Rascovsky K, Kramer JH, Weiner M, Miller BL, Gorno-Tempini ML (2008) Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 65:249&#x2013;255. 10.1001/archneurol.2007.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2007.38</ArticleId><ArticleId IdType="pmc">PMC2544627</ArticleId><ArticleId IdType="pubmed">18268196</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW, Zhou J, Kim E-J (2012) Frontotemporal dementia: what can the behavioral variant teach us about human brain organization? Neuroscientist 18:373&#x2013;385. 10.1177/1073858411410354</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858411410354</ArticleId><ArticleId IdType="pubmed">21670424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, Dejesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Seeley W, Miller BL, Boxer AL (2012) Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 79:1002&#x2013;1011. 10.1212/WNL.0b013e318268452e</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318268452e</ArticleId><ArticleId IdType="pmc">PMC3430713</ArticleId><ArticleId IdType="pubmed">22875087</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. . (2018) Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med 24:313&#x2013;325. 10.1038/nm.4490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, S&#xf8;rensen SA, Gydesen S, Fisher EMC, Collinge J (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37:806&#x2013;808. 10.1038/ng1609</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Ghirelli A, Basaia S, Cividini C, Riva N, Canu E, Castelnovo V, Domi T, Magnani G, Caso F, Caroppo P, Prioni S, Rossi G, Tremolizzo L, Appollonio I, Silani V, Carrera P, Filippi M, Agosta F (2021) Structural MRI signatures in genetic presentations of the frontotemporal dementia-motor neuron disease spectrum. Neurology 97:e1594&#x2013;e1607. 10.1212/WNL.0000000000012702</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012702</ArticleId><ArticleId IdType="pmc">PMC8548958</ArticleId><ArticleId IdType="pubmed">34544819</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, Hortob&#xe1;Gyi T, Rosenfeld J, Silani V, Ince PG, Turner MR (2017) Amyotrophic lateral sclerosis&#x2013;frontotemporal spectrum disorder (ALS&#x2013;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18:153&#x2013;174. 10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545&#x2013;15550. 10.1073/pnas.0506580102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Samimi H, Gamez M, Zare H, Frost B (2018) Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 21:1038&#x2013;1048. 10.1038/s41593-018-0194-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0194-1</ArticleId><ArticleId IdType="pmc">PMC6095477</ArticleId><ArticleId IdType="pubmed">30038280</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, NYGC ALS, Consortium Fagegaltier D, Harris BT, Ostrow LW, Phatnani H, Ravits J, Dubnau J, Gale Hammell M (2019) Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep 29:1164&#x2013;1177.e5. 10.1016/j.celrep.2019.09.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JNS, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, Garcia PA, Rabinovici GD, Coppola G, Geschwind DH, Petrucelli L, Miller BL, Seeley WW (2016) Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain 139:3202&#x2013;3216. 10.1093/brain/aww250</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww250</ArticleId><ArticleId IdType="pmc">PMC5790143</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW (2019) C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol 137:1&#x2013;26. 10.1007/s00401-018-1921-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Vertes RP, Hoover WB (2008) Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat. J Comp Neurol 508:212&#x2013;237. 10.1002/cne.21679</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21679</ArticleId><ArticleId IdType="pubmed">18311787</ArticleId></ArticleIdList></Reference><Reference><Citation>Vertes RP, Linley SB, Hoover WB (2015) Limbic circuitry of the midline thalamus. Neurosci Biobehav Rev 54:89&#x2013;107. 10.1016/j.neubiorev.2015.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2015.01.014</ArticleId><ArticleId IdType="pmc">PMC4976455</ArticleId><ArticleId IdType="pubmed">25616182</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, Duggirala R, Glahn DC (2010) Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 53:1135&#x2013;1146. 10.1016/j.neuroimage.2009.12.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.12.028</ArticleId><ArticleId IdType="pmc">PMC2891595</ArticleId><ArticleId IdType="pubmed">20006715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama JS, Rosen HJ (2012) Neuroimaging features of C9ORF72 expansion. Alzheimers Res Ther 4:45. 10.1186/alzrt148</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt148</ArticleId><ArticleId IdType="pmc">PMC3580454</ArticleId><ArticleId IdType="pubmed">23153366</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama JS, Sirkis DW, Miller BL (2014) C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. Am J Neurodegener Dis 3:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3986607</ArticleId><ArticleId IdType="pubmed">24753999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, et al. . (2019) Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363:eaav2606. 10.1126/science.aav2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, Diaz Garcia S, Ghosh Dastidar S, Rodriguez MJ, King P, Zhang Y, La Spada AR, Xu H, Petrucelli L, Ravits J, Da Cruz S, Lagier-Tourenne C, Cleveland DW (2020) Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci 23:615&#x2013;624. 10.1038/s41593-020-0619-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>